Cigna Group (NYSE:CI) Updates FY 2026 Earnings Guidance

Cigna Group (NYSE:CI) updated its FY 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 30.350- for the period, compared to the consensus earnings per share estimate of 30.330. The company issued revenue guidance of -.

Analyst Ratings Changes

Several brokerages have commented on CI. Piper Sandler decreased their price target on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. UBS Group reissued a “buy” rating and issued a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Robert W. Baird set a $337.00 price target on shares of Cigna Group in a research report on Friday. Raymond James Financial set a $340.00 price target on shares of Cigna Group in a research report on Friday. Finally, Cantor Fitzgerald lifted their price objective on shares of Cigna Group from $325.00 to $340.00 and gave the stock an “overweight” rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $336.20.

Cigna Group Price Performance

Cigna Group stock opened at $283.14 on Friday. The stock has a market cap of $74.62 billion, a P/E ratio of 12.77, a price-to-earnings-growth ratio of 1.01 and a beta of 0.26. The company has a fifty day simple moving average of $274.34 and a 200-day simple moving average of $276.94. Cigna Group has a 12-month low of $239.51 and a 12-month high of $350.00. The company has a current ratio of 0.73, a quick ratio of 0.74 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business had revenue of $68.52 billion during the quarter, compared to analysts’ expectations of $66.29 billion. During the same period in the previous year, the company earned $6.74 EPS. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts expect that Cigna Group will post 30.35 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is 28.13%.

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.60% of the company’s stock.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

Institutional Investors Weigh In On Cigna Group

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Compound Planning Inc. raised its holdings in shares of Cigna Group by 2.7% in the fourth quarter. Compound Planning Inc. now owns 1,944 shares of the health services provider’s stock valued at $535,000 after buying an additional 51 shares during the last quarter. Invesco Ltd. raised its holdings in shares of Cigna Group by 27.4% in the fourth quarter. Invesco Ltd. now owns 2,421,775 shares of the health services provider’s stock valued at $666,545,000 after buying an additional 521,273 shares during the last quarter. Mercer Global Advisors Inc. ADV raised its holdings in shares of Cigna Group by 8.3% in the fourth quarter. Mercer Global Advisors Inc. ADV now owns 47,873 shares of the health services provider’s stock valued at $13,176,000 after buying an additional 3,654 shares during the last quarter. Virtue Capital Management LLC purchased a new stake in shares of Cigna Group in the fourth quarter valued at about $272,000. Finally, Vident Advisory LLC raised its holdings in shares of Cigna Group by 80.5% in the fourth quarter. Vident Advisory LLC now owns 16,210 shares of the health services provider’s stock valued at $4,462,000 after buying an additional 7,230 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.